Certara's Upcoming Financial Results and Conference Engagements

Certara Plans to Share Financial Results Soon

Certara, Inc. (Nasdaq: CERT), a prominent global player in model-informed drug development, has exciting plans ahead. The company is scheduled to announce its financial results for both the fourth quarter and the entire year of 2024. This announcement is set to take place after the market closes on a Wednesday in late February.

Details for the Upcoming Conference Call

Management at Certara will host a conference call aimed at discussing the released financial results on that same day. Investors eager to tune in can access the conference call at 5:00 PM ET. It is recommended for attendees to ensure they register at least a day beforehand to secure their participation.

Participating in Noteworthy Investor Conferences

In addition to the financial announcement, Certara's management team will also play a role in several important investor conferences coming up in the near future. One of the primary events is the Leerink Partners Global Healthcare Conference.

Event Schedule and Details

This conference will occur on a Tuesday, featuring Certara’s participation scheduled for 1:00 PM ET. Following closely is another significant event, the Barclays 27th Annual Global Healthcare Conference.

Conference Participation

This anticipated event will take place on a Wednesday, with Certara scheduled to present at 11:30 AM ET. Both conferences provide an excellent opportunity for investors and stakeholders to gain insights directly from the company’s leadership.

Accessing Conference Webcasts

Those interested in these events will have the option to view live and archived webcasts available in the 'Investors' section of Certara's official website. This feature ensures that all interested parties can stay updated on the latest developments and insights from the company.

The Role of Certara in Drug Development

Certara stands out in the industry by enhancing the drug development process through the use of advanced biosimulation software, technology, and services. The company is dedicated to transforming traditional drug discovery and development methods. It serves a diverse clientele ranging from biopharmaceutical firms to academic institutions and regulatory bodies across the globe.

Client Base and Reach

Certara boasts a client base exceeding 2,400, which places it at the forefront of innovation in drug development practices. With a presence across 66 countries, it continues to leverage its expertise to advance medicine for better patient outcomes. Through these efforts, Certara aids in expediting the vital journey that new drugs must navigate before reaching the market.

Investor Relations and Contact Information

The Investor Relations team is always ready to assist with inquiries and provide further insights. David Deuchler of the Gilmartin Group is available for communication regarding investor relations. Reach out via email to connect and gather more specifics about Certara's initiatives and upcoming announcements.

Media Inquiries Welcome

Alyssa Horowitz is available for those seeking media-related information. An open line of communication ensures that both media representatives and investors can stay informed about Certara's latest developments.

Frequently Asked Questions

1. When will Certara release its financial results?

Certara plans to announce its financial results for the fourth quarter and full year of 2024 on February 26, 2025, after the market closes.

2. How can I listen to the financial conference call?

Investors can listen to the financial conference call by registering online in advance. It's suggested to register at least one day before.

3. What investor conferences will Certara participate in?

Certara will participate in the Leerink Partners Global Healthcare Conference and the Barclays 27th Annual Global Healthcare Conference in March.

4. Where can I find more information about these webcasts?

Live and archived webcasts for the conferences will be available in the “Investors” section of Certara's official website.

5. How does Certara contribute to drug development?

Certara uses biosimulation software and services to transform traditional drug discovery and development processes, helping accelerate the delivery of new medicines.

About The Author

Hello, I'm 30-year-old financial writer and expert Addison Perry, and I love to simplify the intricacies of the financial industry. I've committed myself over the years to deciphering the subtleties of investing techniques and economic trends and converting them into doable guidance that anybody can use. My goal with writings and books is to make money interesting and approachable so that readers may take charge of their financial futures.

My enthusiasm to empowerment and education has propelled me through my career in finance. I write because I think that everyone should be able to make educated financial decisions, and I try to provide that. Regardless of experience level with investing, my work is intended to provide insightful analysis and practical advice to enable you to thrive in the always changing financial environment. I appreciate you traveling with me toward success and financial literacy.

Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.